Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Glaxosmithkline Plc gives FY 2014 EPS guidance and declares fourth interim dividend


Wednesday, 5 Feb 2014 07:00am EST 

Glaxosmithkline Plc:Sees core earning per share (EPS) growth of 4-8 pct. CER (from FY 2013 base of 108.4 pence adjusted for divestments completed during 2013).Sees turnover growth of around 2 pct. CER (from FY 2013 base of 25,602 million pound adjusted for divestments completed during 2013).FY 2014 EPS of 116.67 pence - Thomson Reuters I/B/E/S.Declares a fourth interim dividend of 23 pence per share (Q4 2012: 22 pence per share) making 78 pence for the full year.Says the ex-dividend date will be Feb. 19, with a record date of Feb. 21 and a payment date of Apr. 10. 

Company Quote

1422.0
-21.5 -1.49%
12:11pm EDT